Introduction N-(4-hydroxyphenyl)retinamide (4-HPR, fenretinide) has potent chemopreventive and antimetastatic effects in several animal models (Green et al., 1999; Shaker et al., 2000; Hursting et al., 2001; Raffaghello et al., 2003) and is currently undergoing clinical trials for the prevention of ovarian carcinoma (De Palo et al., 2002) , lung carcinoma (Cai and Jones, 1998) , and breast neoplasia (Levi et al., 2001; Singletary et al., 2001) . In addition, 4-HPR can exert chemotherapeutic effects and kill cancer cells in a variety of in vitro and in vivo models, through the induction of apoptosis (Wu et al., 2001; Fontana and Rishi, 2002) .
Apoptosis is mediated through two main pathways, the extrinsic (death receptor) pathway (Krammer, 2000) and the intrinsic (mitochondrial) pathway (Kroemer and Reed, 2000) . The extrinsic pathway is initiated by ligation of plasma membrane death receptors, which results in a step-wise recruitment of adaptors and initiator caspases (in particular, caspase-8 and -10) into the death-inducing signaling complex (DISC). In some cells (type I), activation of caspase-8 may directly trigger activation of the caspase cascade (Krammer, 2000) bypassing the mitochondrial apoptotic pathway, while in other cells (type II) caspase-8 mediates apoptosis only via proteolytic processing of BID (Li et al., 1998; Letai et al., 2002) , which then, in turn triggers mitochondrial membrane permeabilization (MMP). Some chemotherapeutic agents trigger the extrinsic pathway, by upregulating death receptors (e.g. CD95) and their ligands (e.g. CD95L), either through a type I-or type II-like signaling cascade (Fulda et al., 2001) .
Nonetheless, most chemotherapeutic agents trigger the mitochondrial pathway , which may be induced by various stress signals (Kroemer and Reed, 2000) . In most examples, che-motherapy results in the elicitation of cellular mediators (e.g. Ca 2 þ , reactive oxygen species (ROS), sphingolipids, proapoptotic members of the Bcl-2 family), which then indirectly induce MMP. Some chemotherapeutic agents can induce MMP through a direct action on mitochondrial proteins and lipids (Debatin et al., 2002) . MMP is lethal for the cell because it results in a bioenergetic failure and because it suppresses the rigorous compartmentalization of catabolic enzymes and their activators . Thus, for instance cytochrome c (Cyt c) is confined to the mitochondrial intermembrane space and cannot interact with Apaf-1, a cytosolic protein. Upon permeabilization or rupture of the outer mitochondrial membrane, Cyt c binds to Apaf-1, which becomes an allosteric activator of pro-caspase-9, which in turn proteolytically activates caspase-3, one of the principal proteases participating in the execution of the death sentence (Wang, 2002) . MMP is controlled by several proteins from the Bcl-2 family including Bax and Bak (Ranger et al., 2001; Wei et al., 2001) , two proapoptotic proteins, which participate in local permeabilization reactions (Kuwana et al., 2002; Zamzami and Kroemer, 2003) .
4-HPR has been suggested to induce apoptosis through the mitochondrial pathway (Asumendi et al., 2002) , and tumor cells lacking a functional respiratory chain fail to undergo apoptosis in response to 4-HPR (Hail and Lotan, 2001) . We described in the past that another retinoid, 6-[3-(1-adamantyl)-4-hydroxyphenyl]-2-naphtalene carboxylic acid (CD437), induces apoptosis through a direct action on mitochondria (Marchetti et al., 1999; Belzacq et al., 2001) . Indeed, CD437 can permeabilize isolated mitochondria in vitro in a reaction that is prevented by cyclosporin A, a ligand of mitochondrial cyclophilin D, and bongkrekic acid, a ligand of the adenine nucleotide translocase (ANT) (Marchetti et al., 1999) . Both cyclophilin D and ANT are components of the so-called permeability transition pore complex (PTPC) , which participates in the regulation of apoptotic MMP (Zamzami and Kroemer, 2003) . Accordingly, CD437 permeabilizes proteoliposomes containing the purified PTPC or ANT (Belzacq et al., 2001) , suggesting that (one of) its molecular target(s) is indeed ANT. Some investigators reported that 4-HPR-induced apoptosis (as tested on whole cells) would be inhibited by cyclosporin A and bongkrekic acid (Hail and Lotan, 2000) , but others found that 4-HPR causes the downregulation of cyclophilin D (Hursting et al., 2002) , the cyclosporin A target in mitochondria, and yet other groups reported that bongkrekic acid (You et al., 2002) and cyclosporin A actually enhanced 4-HPR-induced apoptosis (Lim et al., 2002) .
Based on these premises, we decided to reinvestigate the implication of mitochondria in 4-HPR-triggered apoptosis and to assess the molecular mechanisms involved in 4-HPR-induced MMP. Our data indicate that 4-HPR provokes MMP through an indirect, ROSmediated pathway that involves the obligatory contribution of the proapoptotic Bcl-2 family members Bax and/or Bak.
Results and discussion

4-HPR induces MMP upstream of caspase-3 activation and nuclear apoptosis
Human tumor cell lines such as the T-cell acute lymphoblastic leukemia line CCRF-CEM were exposed to 4-HPR and the frequency of cells exhibiting a loss of the mitochondrial transmembrane potential (DCm) was determined by assessing the incorporation of the DCmsensitive dye chloromethyl-X-rosamine (CMXRos) (Macho et al., 1996; Metivier et al., 1998) . Simultaneously, the frequency of cells capable of digesting the fluorogenic caspase substrate rhodamine 110-Asp 2 (Asp 2 R110) was determined by cytofluorometry ( Figure 1a ). This double-staining procedure allows for the direct assessment of the sequence of apoptosisassociated events (Castedo et al., 2002) . The DCm dissipation induced by 4-HPR clearly preceded the activation of caspase-3, as indicated by kinetic analysis (Figure 1a 4-hydroxyphenylretinamide-induced mitochondrial apoptosis P Boya et al cells were found to accumulate mitochondrion release of Cyt c (Figure 2a ) well before they contained significant levels of activated caspase-3 (Casp-3a) (Figure 2b ). This was confirmed at the single-cell level by immunofluorescence analysis, showing that the subcellular distribution Cyt c shifted from a punctate cytoplasmic (mitochondrial) to a diffuse (cytosolic) staining pattern upon treatment with 4-HPR. Caspase-3 activation, as detected with an antibody specific for a neoepitope created by proteolytic maturation of caspase-3, was strictly confined to those cells with diffuse Cyt c (Figure 2c ). Inhibition of caspase-3 activation by addition of the pan-caspase inhibitor N-benzyloxycarbonyl-Val-Ala-Asp-fluoromethylketone (Z-VAD.fmk) failed to prevent Cyt c release, thus confirming that MMP occurred upstream of caspase activation. The ROS scavenger vitamin E (a-tokopherol) efficiently inhibited the Cyt c release as well as caspase activation (Figure 2a, b) , suggesting that ROS plays some role in 4-HPR-induced MMP.
4-HPR-induced caspase activation and cell death are inhibited by the MMP inhibitors Bcl-2 and vMIA Bcl-2 is located on both mitochondria and the endoplasmic reticulum, and is thought to inhibit apoptosis by preventing MMP , as well as by effects on the endoplasmic reticulum involving the local retention of proapoptotic proteins and/or effects on Ca 2 þ signaling (Pinton et al., 2001; Thomenius et al., 2003) . In contrast to Bcl-2, the viral mitochondrial inhibitor of apoptosis (vMIA, encoded by the UL37 gene of Cytomegalovirus) is strictly confined to the mitochondrial fraction where it exerts a local MMPinhibitory effect (Goldmacher et al., 1999; Hayajneh et al., 2001; McCormick et al., 2003) . Both Bcl-2 and vMIA inhibited the induction of apoptosis-associated alterations induced by 4-HPR, including the loss of the DCm (determined by staining with 3,3 0 dihexyloxacarbocyanine iodide, DiOC 6 (3)), the loss of viability (determined by staining with propidium iodide, PI), the production of superoxide anion (determined by the oxidation of nonfluorescent hydroethidine to fluorescent ethidium), and the activation of caspase-3 (determined with Asp 2 R110) ( Figure 3a) . Thus, 4-HPR-induced apoptosis was efficiently inhibited by both Bcl-2 and HeLa cells were treated with 4-HPR at the indicated doses for 24 h and stained with the DC m -sensitive dye DiOC 6 (3), the vital dye PI, the ROS-sensitive dye HE, and (Asp) 2 -R110 (for the detection of active caspases), as described in Materials and methods. The percentages (X7s.e.m., n ¼ 4) of cells with a low C m , permeabilized plasma membranes (PI þ ), elevated ROS and activated caspases are plotted. (b) HeLa cells pretreated with vitamin E and z-VAD.fmk (100 mm, 2 and 1 h, respectively) were further incubated with 4-HPR (24 h) and simultaneously stained with DiOC 6 (3) and PI, followed by cytofluorometric analysis 4-hydroxyphenylretinamide-induced mitochondrial apoptosis P Boya et al vMIA, at all levels, indicating that MMP is truly a critical event in 4-HPR-induced apoptosis. Vitamin E also reduced the frequency of DCm low cells. In contrast, Z-VAD.fmk had no effect on the DCm loss, although it did retard the loss of cellular viability induced by 4-HPR (Figure 3b ).
No direct action of 4-HPR on the mitochondrial PTPC
Based on the fact that several retinoid derivatives act on isolated mitochondria (Marchetti et al., 1999; Notario et al., 2003) , we wondered whether 4-HPR might have a direct MMP-inducing effect. When added to purified mitochondria, 4-HPR failed to induce large amplitude swelling (Figure 4a ) and did not cause the release of Cyt c (Figure 4b ). Next, we investigated the effect of 4-HPR on proteoliposomes containing the purified PTPC and quantified their permeabilization by measuring the release of encapsulated 4-methylumbelliferylphosphate (4-MUP). All-trans retinoic acid (atRA) reportedly interacts with the ANT, a component of the PTPC, and induces PTPC opening through a direct effect (Notario et al., 2003) , although this has not been tested on proteoliposomes. Unexpectedly, we found that atRA did not cause the permeabilization of PTPC proteoliposomes and rather prevented their permeabilization in response to atractyloside (Atr) or Ca 2 þ ( Figure 5 ). This effect was achieved at a rather high dose, which is a dose 10 times higher than usually required for cellular effects, and thus is unlikely to be pharmacologically relevant. Similarly, 4-HPR failed to permeabilize PTPC proteoliposomes and rather inhibited their permeabilization, although less efficiently than atRA (Figure 5a, b) . Altogether, these data indicate that 4-HPR does not induce MMP through a direct action of mitochondria or on the mitochondrial PTPC.
4-HPR-induced apoptosis is not modulated by NF-kB or p53
4-HPR has been suggested to act via p53 (Zou et al., 2002) and NF-kB (Shimada et al., 2002) . A chemical inhibitor of the nuclear translocation of NF-kB, SN50 was inefficient in modulating the 4-HPR-induced DCm loss and cell death (Figure 6a) . Similarly, a cell line engineered to overexpress a dominant-negative inhibitor of NF-kB (IkB) together with GFP, in a tetracyclininducible (Tet-on) manner, underwent 4-HPR-induced DCm loss (Figure 6b, d ) and death (Figure 6c, d) , irrespective of the absence or the presence of the IkBinducing agent doxycyclin. In control experiments, however, IkB-overexpressing cells were sensitized to the apoptosis-inducing effect of tumor necrosis factor-a (Feuillard et al., 2000, data not shown) . In a further series of experiments, we compared the effect of 4-HPR on HCT-116 colon carcinoma cells that express p53 or lack p53 expression as a result of homologous recombination (Bunz et al., 1999) . The absence of p53 failed to affect 4-HPR-induced apoptosis ( Figure 7) . As a side observation, two HCT-116 cell sublines selected for oxaliplatin resistance (Gourdier et al., 2002) , were found to respond normally to HPR, indicating that HPR can kill cells that are resistant to conventional chemotherapy. However, the important observation is that 4-HPR-induced apoptosis does not require p53, in line with the fact that 4-HPR can actually exert chemopreventive effects in p53-deficient mice (Hursting et al., 2001) or in animals inoculated with p53-negative tumor cell lines (Shaker et al., 2000) . 
4-HPR-induced apoptosis involves the obligate contribution of Bax and Bak
The proapoptotic proteins Bax and Bak can undergo a conformational change that accompanies their apoptotic activation (Korsmeyer et al., 2000; Letai et al., 2002) . This change consists in the exposure of the N-termini, which are normally buried within the a-helical bundles of Bax and Bak (Griffiths et al., 1999; Suzuki et al., 2000) and can be detected with suitable monoclonal antibodies (Ab-1 for Bak and 6A7 for Bax). While untreated cells exhibit no staining with the Bak-specific Ab-1 antibody (Figure 8a ) or a diffuse staining with the Bax-specific 6A7 (Figure 8b ), 4-HPR-treated cells exhibit a bright, punctate cytoplasmic staining pattern with both Ab-1 and 6A7 (Figure 8a, b) , consistent with the conformational activation of Bax/Bak and the mitochondrial relocalization of Bax. These changes, as well as the mitochondrial Cyt c release (Figure 8c ), were inhibited by vitamin E (Figure 8d ), suggesting that they are secondary to the generation of ROS. To directly assess the involvement of Bax and Bak in the cytocidal activity of 4-HPR, we took advantage of mouse embryonic fibroblasts (MEF) lacking both Bax and Bak as a result of a double knockout (DKO). Such Bax À/À Bak À/À cells conserved a normal DCm and viability when exposed to 4-HPR, while wild-type control cells (Bax þ / þ Bak þ / þ ) manifested progressive DCm dissipation and cell death (Figure 9a, b) . Intriguingly, Bax À/À Bak À/À MEF also failed to produce hydroethidin-detectable ROS, when stimulated with 4-HPR (Figure 9c, d) . Altogether, these data indicate that activation of Bax and/or Bak is pivotal for 4-HPRinduced apoptosis. -c) and/or vitamin E (100 mm) were also stained for the detection of active caspase-3 (as in Figure 2c ), and the frequency of the indicated staining patterns were determined. Results are mean values of triplicates7s.e.m.
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Concluding remarks
The data presented in this paper reveal important insights into the mechanisms of apoptosis induction by 4-HPR, a promising chemopreventive and chemotherapeutic agent. 4-HPR induces apoptosis through a rigorously mitochondrion-controlled mechanism. This is indicated by the fact that 4-HPR induces early How 4-HPR induces MMP, however, remains a partially unresolved issue. From our data, it appears clear that 4-HPR does not induce MMP via a direct mechanism. Thus, isolated mitochondria (Figure 4 ) as well as PTPC proteoliposomes ( Figure 5 ) failed to permeabilize in response to 4-HPR. This strongly contrasts with the direct MMP-inducing effects reported for CD437 (Marchetti et al., 1999) , which acts on the reconstituted PTPC as well as on ANT proteoliposomes (Belzacq et al., 2001) . Thus, CD437 and 4-HPR must act on different targets, in line with the evidence that CD437-resistant cell lines are not cross-resistant to 4-HPR (Holmes et al., 2002) and vice versa (Appierto et al., 2001) .
The ability of 4-HPR to induce MMP in intact cells must involve mediators generated outside of mitochondria. On theoretical grounds, such 4-HPR-elicited mediators may include ceramide (Wang et al., 2001; Erdreich-Epstein et al., 2002) , ganglioside GD3 derived from ceramide (DeMaria et al., 1997; Rippo et al., 2000; Prinetti et al., 2003) , and ROS produced by the respiratory chain (Hail and Lotan, 2001) , and/or the lipoxygenase (Lovat et al., 2002) . We found that antioxidants such as vitamin E and glutathion ethyl ester (not shown) can prevent all manifestations of 4-HPR-induced apoptosis, including all signs of MMP (Figure 2 and 8) . Intriguingly, vitamin E curtailed the 4-HPR-induced conformation change of Bax and Bak, as well as the relocation of Bax to mitochondria, suggesting that ROS might act upstream of Bax and Bak. However, we also observed that transfection-enforced overexpression of Bcl-2, transfection with vMIA and the knockout of Bax/Bak greatly reduced the production of ROS by 4-HPR-stimulated cells. This in turn would suggest that the molecular events controlled by the Bcl-2/Bax family occur upstream of the 4-HPR-induced ROS generation. As a possible solution of this dilemma, we might invoke the fact that MMP and ROS can be involved in a feed-forward amplification loop in which increased ROS levels cause MMP and MMP leads to an increased production of ROS, as this has been reported in several systems (Costantini et al., 1996; Cai and Jones, 1998; Susin et al., 1998; Zorov et al., 2000) . In this scenario, both antioxidants and MMP-inhibition would have similar effects, resulting in the inhibition of ROS generation and the maintenance of mitochondrial function with a consequent inhibition of the apoptotic pathway.
Although it appears clear that both ROS and Bax/ Bak-mediated MMP are critical for 4-HPR-induced apoptosis, the ultimate pharmacological target of 4-HPR remains elusive. Future studies must identify this target, which may facilitate the development of further anticancer drugs with a similar mode of action.
Materials and methods
Cell lines and culture conditions
CCRF-CEM human lymphoblastoid leukemia cells were grown in RPMI 1640 (Biomedia) supplemented with 10% heat-inactivated fetal bovine serum, 100 mg/ml gentamicine and 2 mm l-glutamine. SV-40 transformed murine embryonic fibroblasts (kindly provided by Dr Stanley Korsmeyer), WT, and Bax À/À Bak À/À DKO were cultivated in IMDM (Life Technologies) supplemented with 10% fetal bovine serum, 1 Â nonessential amino acids (Sigma), and 100 U/ml penicillin/ streptomycin, both at 371C under 5% CO 2 . HeLa cells were stably transfected with pcDNA3.1 control vector (Neo), with human Bcl-2 (Bcl-2) or the Cytomegalovirus UL37 exon 1 gene (vMIA, kindly provided by Dr V Goldmacher). HeLa cells or HT116 cells (wild-type, knockout for p53 kindly provided by Dr B Vogelstein, or cells selected for oxaliplatin resistance) were cultured in DMEM medium supplemented with 10% FCS, 1 mm pyruvate, 10 mm HEPES, and 100 U/ml penicillin/ streptomycin at 371C under 5% CO 2 . Lymphocytes B immortalized with the Epstein-Barr virus were transfected with an episomal Tet-on a double inducible construct containing the cassette encoding the optimized Green Fluorescent Protein EGFP and the cassette encoding the mutated dominant-negative I-kB alpha cDNA under the control of the bidirectional tetO7 tetracyline-responsive promoter (Feuillard et al., 2000) . These cells were cultured in RPMI 1640 (Biomedia) supplemented with 10% fetal calf serum, 100 U/ml penicillin, 10 mg/ml streptomycin (GibcoBRL, Life Technologies), and 2 mm l-glutamine (Eurobio), at 371C in a humidified 5% CO 2 atmosphere. The selection of hygromycin-resistant cells and doxycycline treatment was performed as described (Feuillard et al., 2000) . The human colorectal cancer cell lines HCT116/S, HCT116/R1, and HCT116/R2 were derived from the parental HCT116 cell line (ATCC) and were grown in RPMI 1640 medium supplemented with 10% foetal bovine serum and 2 mm glutamine without antibiotics. The two oxaliplatin resistant clones (HCT116/R1 and HCT116/R2) were selected by exposure to stepwise increased concentrations of oxaliplatin and were maintained in the presence of oxaliplatin as previously described (Gourdier et al., 2002) .
Apoptosis induction and inhibition
For apoptosis induction, cells were cultured in the presence of 4-HPR (Sigma). The caspase inhibitor z-VAD.fmk 100 mm (Bachem) was added 1 h prior to induction of apoptosis and the antioxidant vitamin E 100 mm (Sigma) was added 2 h before the drug. For NF-kB inhibition, the peptide SN50 and its control (mutated SN50M; Biomol) were added at a concentration of 50 mm.
Flow cytometry
Cytofluorometry analyses were performed on a FACS all of them from Molecular Probes, were DiOC 6 (3) (40 nm), CMXRos (100 nm), and TMRE (150 nm) for DC m quantification, PI (5 mg/ml) and DAPI (10 mg/ml) for determination cell viability, HE (10 mm) for the determination of superoxide anion generation, and Asp 2 R110 (20 mm) to measure caspase activity.
Drug sensitivity assay
Growth inhibition assays were performed by seeding 4000 cells per well in 96-well microtiter plates. After incubation for 24 h for cell attachment, 4-HPR was added and the cells (HCT116/ S, HCT116/R1, HCT116/R2, or HCT116/p53KO) were incubated again for 24, 48, or 72 h. Each drug concentration was tested in triplicate. Cytotoxicity was measured by the WST-1 colorimetric assay (Boehringer Mannheim, Germany) according to the manufacturer's recommendations. Absorbance was measured at 450 nm 3 h after addition of the WST-1 substrate.
Immunofluorescence and light microscopy
Cells were cultured on cover slips and in cover slips pretreated with poly-l-lysine 0.001% (Sigma) for cell adhesion in the case of CCRF-CEM cells. After apoptosis induction, cells were fixed on paraformaldehyde (4% w : v) and picric acid (0.19% w : v) for immunofluorescence assays (Castedo et al., 2001) . Cells were stained for the detection of Cyt c (mAB 6H2.B4 from Pharmigen), Casp-3a (anti-cleaved caspase-3 from Cell Signaling Technology), activated Bax (mAb 6A7, Pharmingen), activated Bak (mAb Ab-1 specific for the NH 2 terminus, Oncogene), detected by anti-mouse and anti-rabbit IgG conjugated with Alexa s fluor (Molecular Probes), and counterstained with Hoechst 33342 (Molecular Probes) before mounting. Bars represent 10 mm.
Western blot
Cell pellets were resuspended at 41C in 300 ml HNB buffer (10 mm PIPES, 2 mm MgCl 2 , 10 mm KCl pH 7.4), supplemented with 1 mm DTT, 0.1 mm PMSF, 20 mm cytocalasin B, and protease inhibitor cocktail (Roche). The cells were then disrupted by homogenization on ice by a douncer (150 strokes), and the homogenate was subjected to 30% sacharose gradient. After centrifugation at 1200 g for 15 min, the supernatant was collected and subjected to centrifugation at 10 000 g for 30 min at 41C. The mitochondrial pellet was removed and the supernatant was subjected to another centrifugation at 46 000 g for 1 h to obtain a cytosolic extract. The total protein content was determined with the Bio-RAD DC kit. Samples of the cytosolic extracts containing 20 mg protein were loaded on a 12% SDS-polyacrylamide gel, transferred to nitrocellulose membranes and subjected to immunodetection of Cyt c (mAb 6H2.B4 from Pharmingen) and Casp-3a (antibody from Cell Signaling Technology) using the chemiluminescence ECL method (Pierce Supersignal s ). Equal loading and transfer of proteins was controlled by Ponceau red stainings of the nitrocellulose membranes.
Mitochondria swelling
Mitochondria were purified from BALB/c mouse livers on a Percoll gradient . Mitochondrial protein (1 mg) was resuspended in 0.2 m sucrose, 10 mm Tris-MOPS, pH 7.4, 5 mm succinate-Tris, 1 mm Na 3 PO 4 , 2 mm rotenone, and 10 mm EGTA-Tris (swelling buffer). PT pore opening was monitored as the change of 901 light scattering at 540 nm, using a Hitachi F-4500 fluorescence spectrophotometer. For Cyt c translocation, 20 mg of mouse liver mitochondria were incubated 30 min at 41C with different concentrations of 4-HPR in swelling buffer, and centrifuged at 10 000 g for 10 min to precipitate mitochondria. The supernatant and the pellet (mitochondria) were subjected to Western blot for Cyt c as described above.
PTPC purification and reconstitution
The PTPC was purified as previously described (Brenner et al., 2000) . Crude mitochondria were prepared from four rat brains by homogenization in 1 mm a-hioglycerol-10 mm glucose (pH 8.0) and centrifugation (2 Â 15 min, 12 000 g, 41C). Following solubilization (0.5% (v : v) Triton X-100 (Roche, membrane research grade), 30 min, room temperature) and ultracentrifugation (40 min, 50 000 g, 41C), soluble proteins were mixed with 15-20 g of DE52 resin (Whatman) in buffer A (1.5 mm Na 2 HPO 4 , 1.5 mm K 2 HPO 4 , 0.1 mm glucose, and 1 mm DTT (pH 8.0)). An FPLC column (Amersham) was then filled with the resin, and after equilibration with 6 ml of buffer A, proteins were eluted with a linear gradient of KCl (from 50 to 400 mm KCl) at a flow rate of 0.8 ml/min. Hexokinase activitycontaining fractions were mixed (v : v) with preformed phosphatidylcholine-cholesterol (5 : 1) lipid vesicles and dialysed overnight at 41C to eliminate surfactants traces. Resulting PTPC containing liposomes were kept at -201C until use.
Pore opening assay
Proteoliposomes were sonicated in the presence of 1 mm 4-MUP, 10 mm KCl, 125 mm saccharose, 10 mm HEPES (pH 7.4) on ice (100 W, 22 s, Misonix sonifier 550 W) as described (Belzacq et al., 2001) . Unencapsulated products were eliminated by separation on Sephadex G25 columns (PD-10, Amersham). Aliquots of proteoliposomes (25 ml) were dispended in microtiter plates in triplicate to monitor 4-MUP release. Briefly, proteoliposomes were treated by addition of various doses of Atr and calcium as pore opening inducers (60 min, room temperature) or by atRA and 4-HPR (60 min alone, or 30 min before inducers when used as inhibitors, room temperature). Alkaline phosphatase (5 U/ml, Roche) was added in the presence of 0.5 mm MgCl 2 and the plates were incubated for 15 min at 371C to convert the 4-MUP that has been released from proteoliposomes in 4-methylumbelliferone (4-MU). MU fluorescence was determined in a TECAN spectrofluorimeter (l exc 360 nm; l em 465 nm). 4-MUP release of 100% was established as the release induced by 1 mm Atr and respective percentages of 4-MUP release induced by other agents (Ca 2 þ , atRA, 4-HPR) were determined. All experiments were repeated at least three times.
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